Barriers and Solutions Towards Integrating Orthobiologics into Clinical Orthopaedic Practice.
作者信息
Jeyaraman Madhan, Muthu Sathish, Amarnath S S
机构信息
Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai, Tamil Nadu India.
Department of Orthopaedics, Government Karur Medical College, Karur, Tamil Nadu India.
出版信息
Indian J Orthop. 2024 Jul 11;58(8):987-990. doi: 10.1007/s43465-024-01221-4. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
Barriers and Solutions Towards Integrating Orthobiologics into Clinical Orthopaedic Practice.将骨科生物制剂整合到临床骨科实践中的障碍与解决方案
Indian J Orthop. 2024 Jul 11;58(8):987-990. doi: 10.1007/s43465-024-01221-4. eCollection 2024 Aug.
2
Should I add orthobiologics to my knee osteotomy practice? A systematic review.我是否应该在我的膝关节截骨手术中加入骨科生物制剂？一项系统评价。
J ISAKOS. 2024 Dec;9(6):100282. doi: 10.1016/j.jisako.2024.06.001. Epub 2024 Jun 6.
3
Orthobiologics and hyaluronic acid usage in the Netherlands: an electronic survey of 265 orthopaedic surgeons and sports physicians.荷兰的矫形生物制品和透明质酸使用情况：对265名骨科医生和运动医学医生的电子调查。
J Exp Orthop. 2021 Aug 19;8(1):66. doi: 10.1186/s40634-021-00380-9.
4
Identifying barriers and facilitators of translating research evidence into clinical practice: A systematic review of reviews.将研究证据转化为临床实践的障碍和促进因素的识别：系统评价综述。
Health Soc Care Community. 2022 Nov;30(6):e3265-e3276. doi: 10.1111/hsc.13898. Epub 2022 Jul 1.
5
Utilization of Orthobiologics by Sports Medicine Physicians: A Survey-based Study.运动医学医师对矫形生物制剂的应用：一项基于调查的研究。
J Am Acad Orthop Surg Glob Res Rev. 2021 Jan 6;5(1):e20.00185. doi: 10.5435/JAAOSGlobal-D-20-00185.
6
Orthobiologics in Foot and Ankle Arthrodesis: A Systematic Review.足部和踝关节融合术的骨生物学：系统评价。
J Foot Ankle Surg. 2021 Sep-Oct;60(5):1029-1037. doi: 10.1053/j.jfas.2020.09.022. Epub 2021 Apr 20.
7
Experts Achieve Consensus on a Majority of Statements Regarding Ethics, Transparency, Regulation, and Best Practices for the Use of Orthobiologics.专家们就关于使用骨科生物制剂的伦理、透明度、监管及最佳实践的大多数声明达成了共识。
Arthroscopy. 2025 Feb 10. doi: 10.1016/j.arthro.2025.01.062.
8
Orthobiologics: Current role in Orthopedic Surgery and Traumatology.骨科生物制剂：在骨外科与创伤学中的当前作用。
Arch Bone Jt Surg. 2022 Jul;10(7):536-542. doi: 10.22038/ABJS.2021.52770.2614.
9
"Dr. AI Will See You Now": How Do ChatGPT-4 Treatment Recommendations Align With Orthopaedic Clinical Practice Guidelines?“AI 医生为您服务”：ChatGPT-4 的治疗建议与骨科临床实践指南如何契合？
Clin Orthop Relat Res. 2024 Dec 1;482(12):2098-2106. doi: 10.1097/CORR.0000000000003234. Epub 2024 Sep 6.
10
Best Evidence Summary for the Prevention of Pressure Injuries in Orthopaedic Patients.骨科患者压疮预防的最佳证据总结。
J Clin Nurs. 2024 Dec;33(12):4651-4664. doi: 10.1111/jocn.17507. Epub 2024 Oct 27.
引用本文的文献
1
Orthobiologics Revisited: A Concise Perspective on Regenerative Orthopedics.再谈生物 orthobiologics：再生骨科的简明视角
Curr Issues Mol Biol. 2025 Apr 2;47(4):247. doi: 10.3390/cimb47040247.
2
Fixation of Lateral Extra-articular Tenodesis With a Biointegrative Compression Staple.使用生物整合加压钉固定外侧关节外肌腱固定术
Arthrosc Tech. 2024 Dec 28;14(5):103399. doi: 10.1016/j.eats.2024.103399. eCollection 2025 May.
3
Biologic Therapies in the Management of Sports-Related Tendon and Ligament Injuries: A Narrative Review.生物疗法在运动相关肌腱和韧带损伤管理中的应用：一篇叙述性综述
Cureus. 2025 May 21;17(5):e84556. doi: 10.7759/cureus.84556. eCollection 2025 May.
本文引用的文献
1
Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU.细胞和基因治疗监管、定价和报销框架：以韩国和欧盟为例。
Front Public Health. 2023 Feb 24;11:1109873. doi: 10.3389/fpubh.2023.1109873. eCollection 2023.
2
The Efficacy of Platelet-Rich Plasma Injection Therapy in the Treatment of Patients with Achilles Tendinopathy: A Systematic Review and Meta-Analysis.富血小板血浆注射疗法治疗跟腱病患者的疗效：一项系统评价与Meta分析
J Clin Med. 2023 Jan 28;12(3):995. doi: 10.3390/jcm12030995.
3
PRISMA-Compliant Meta-Analysis of Randomized Controlled Trials on Osteoarthritis of Knee Managed with Allogeneic vs Autologous MSCs: Efficacy and Safety Analysis.关于同种异体与自体间充质干细胞治疗膝关节骨关节炎的随机对照试验的PRISMA合规荟萃分析：疗效与安全性分析。
Indian J Orthop. 2022 Sep 20;56(12):2042-2059. doi: 10.1007/s43465-022-00751-z. eCollection 2022 Dec.
4
Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective.间充质干细胞疗法作为一种高级治疗用药品（ATMP）的发展——印度视角
Bioengineering (Basel). 2022 Mar 7;9(3):111. doi: 10.3390/bioengineering9030111.
5
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?我该如何评估未经证实的细胞疗法的安全性和合法性？
Transfusion. 2022 Mar;62(3):518-532. doi: 10.1111/trf.16814. Epub 2022 Feb 10.
6
Platelet-Rich Plasma, Bone Morphogenetic Protein, and Stem Cell Therapies.富血小板血浆、骨形态发生蛋白和干细胞疗法。
Instr Course Lect. 2020;69:273-288.
7
From bench to FDA to bedside: US regulatory trends for new stem cell therapies.从实验室到美国食品药品监督管理局再到临床应用：美国新型干细胞疗法的监管趋势
Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7.
Zotero 插件